ClinConnect ClinConnect Logo
Search / Trial NCT01692613

Endomicroscopy, IBS and Food Intolerance

Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Sep 20, 2012

Trial Information

Current as of May 20, 2025

Completed

Keywords

ClinConnect Summary

The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age \> 18 years
  • ongoing abdominal symptoms such as bloating and abdominal pain
  • negative routine testing for food intolerance (or known lactose/fructose intolerance)
  • written informed consent
  • Exclusion Criteria:
  • no consent
  • known reason for the abdominal pain and bloating other than lactose/fructose intolerance
  • M. Whipple
  • known infectious gastrointestinal disease
  • stricture in the upper gastrointestinal tract
  • age \>18years
  • impaired renal function (Creatinine \>1.2 mg/dL)
  • pregnancy or breast feeding
  • inability to obtain informed consent
  • active GI Bleeding
  • known allergy to Methylene blue or Fluorescein
  • participation in other clinical trials within the last 4 weeks

About University Hospital Schleswig Holstein

University Hospital Schleswig-Holstein (UKSH) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution, UKSH integrates cutting-edge medical research with comprehensive patient care, fostering an environment that promotes the development of novel therapeutic strategies. With a multidisciplinary approach and a strong emphasis on collaboration, UKSH is dedicated to enhancing clinical outcomes and contributing to the global medical community through rigorous scientific inquiry and the translation of research findings into practice.

Locations

Kiel, , Germany

Patients applied

0 patients applied

Trial Officials

Annette Fritscher-Ravens, Prof. Dr.

Principal Investigator

University Schleswig-Holstein

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials